Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription 22.09.2025 1 AJR Am J Roentgenol 1 Am J Pathol 6 Ann Surg Oncol 1 BMC Cancer 1 Br J Cancer 1 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 2 Breast Cancer Res Treat 1 Breast J 2 Cancer Res 13 Clin Breast Cancer 4 Eur J Cancer 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Invest 3 J Clin Oncol 1 J Surg Oncol 2 NPJ Breast Cancer 1 Oncogene 1 Oncol Rep 4 PLoS One 1 Proc Natl Acad Sci U S A 2 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. NGUYEN DL, Grimm LJ, Wells VA, Shpanskaya K, et al
   Echogenic Rind Associated With Suspicious Masses on Ultrasound: Performance for Breast Cancer Diagnosis and Associations With Pathologic Tumor Characteristics.
   AJR Am J Roentgenol. 2025 Sep 17. doi: 10.2214/AJR.25.33732.
   PubMed         Abstract available
   
   

   
   Am J Pathol

2. ACCATTATIS FM, Gelsomino L, Manna L, Del Console P, et al
   Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor-positive Breast Cancer Cells.
   Am J Pathol. 2025 Sep 12:S0002-9440(25)00336.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. HUANG SY, Murray M, Rubio A, Okoro N, et al
   Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
   Ann Surg Oncol. 2025 Sep 13. doi: 10.1245/s10434-025-18288.
   PubMed         Abstract available
   
   
4. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
   ASO Visual Abstract: Medicaid Expansion Is Associated With Lower Mortality in Patients With Locally Advanced Breast Cancer.
   Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18159.
   PubMed        
   
   
5. ARIMA J, Chida K, Wu R, Taniguchi K, et al
   ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?
   Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18377.
   PubMed        
   
   
6. ARIMA J, Chida K, Wu R, Taniguchi K, et al
   ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
   Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18260.
   PubMed         Abstract available
   
   
7. MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
   ASO Visual Abstract: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
   Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18256.
   PubMed        
   
   
8. ZATECKY J, Coufal O
   De-escalation of Axillary Surgery in Inflammatory Breast Cancer: The Right Time is Coming.
   Ann Surg Oncol. 2025 Sep 15. doi: 10.1245/s10434-025-18356.
   PubMed        
   
   

   
   BMC Cancer

9. JANG MK, Park S, Jeon JY, Kang MJ, et al
   Correction: Evaluating the effects of a resistance exercise intervention for sarcopenia in patients receiving neoadjuvant chemotherapy for breast cancer: study protocol for a randomized controlled trial.
   BMC Cancer. 2025;25:1422.
   PubMed        
   
   

   
   Br J Cancer

10. STEGGALL J, Rajeeve V, Al-Subaie N, Naeem A, et al
    Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer.
    Br J Cancer. 2025 Sep 13. doi: 10.1038/s41416-025-03174.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

11. ORDUNA-MEDINA FM, Diaz de Leon-Martinez L, Alarcon-Rivera GDD, Prieto-Gomez NA, et al
    Utility of Volatile Organic Compounds and Electronic Nose Technology for Breast Cancer Detection: A Systematic Review.
    Breast Cancer (Dove Med Press). 2025;17:805-817.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

12. REEVES KW, Oulhote Y, Grandjean P, Nielsen F, et al
    Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast.
    Breast Cancer Res. 2025;27:148.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

13. JI L, Chen X, Lyu H, Song G, et al
    Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscape.
    Breast Cancer Res Treat. 2025 Sep 17. doi: 10.1007/s10549-025-07822.
    PubMed         Abstract available
    
    
14. GRACIANO N, Lopez L, Rodriguez CA, Montoya K, et al
    Survival impact of adjuvant capecitabine in triple-negative breast cancer Latin American patients with residual disease: a real-world study.
    Breast Cancer Res Treat. 2025 Sep 16. doi: 10.1007/s10549-025-07814.
    PubMed         Abstract available
    
    

    
    Breast J

15. ZHANG L, Zhu G, Wang K, Zhang T, et al
    Morphological Assessment of Breast Lesions With Type 2 Dynamic Curves Using DWI and T2WI Based on Breast Imaging Reporting and Data System Lexicon Descriptors.
    Breast J. 2025;2025:9957678.
    PubMed         Abstract available
    
    

    
    Cancer Res

16. TAO JJ, Vasan N
    A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast Cancer.
    Cancer Res. 2025;85:3371-3372.
    PubMed         Abstract available
    
    
17. ZHAO Y, Andoh T, Charles F, Reddy P, et al
    A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.
    Cancer Res. 2025;85:3399-3415.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

18. ELGHAZALY S, Fakeh S, Elbarbary S, Mahmoud K, et al
    Robot-Assisted Versus Open Surgery in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025 Aug 30:S1526-8209(25)00246.
    PubMed         Abstract available
    
    
19. LU J, Xu X, Zhang Y, Zhuang K, et al
    Diagnostic Performance of AI-Assisted Radiologists in Breast Cancer Detection Using Digital Mammography: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025 Aug 21:S1526-8209(25)00239.
    PubMed         Abstract available
    
    
20. CRISTOFALO MM, Reis YN, Maesaka JY, Mota BS, et al
    Occupational Exposure to Ionizing Radiation in Female Physicians and Breast Cancer Risk: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2025 Aug 20:S1526-8209(25)00240.
    PubMed         Abstract available
    
    
21. ALTUNDAG K
    Comment on Clinical Outcomes in Early-Stage Metaplastic Breast Cancer.
    Clin Breast Cancer. 2025 Aug 19:S1526-8209(25)00238.
    PubMed        
    
    
22. LI H, Fan Y, Xu H, Qu H, et al
    The Effects of Compression Therapy at Different Pressure Levels on Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients: A Randomized Controlled Trial.
    Clin Breast Cancer. 2025 Aug 21:S1526-8209(25)00236.
    PubMed         Abstract available
    
    
23. SU M, Saxon-Filipe S, Ahn C, Gao A, et al
    Clinical and Pathological Features of Early-Stage Metaplastic Carcinoma and Associated Patient Outcomes.
    Clin Breast Cancer. 2025;25:693-703.
    PubMed         Abstract available
    
    
24. DIPASQUALE A, Maiato AP, Millochau JC, Sarfati I, et al
    A Novel Level 1 Oncoplastic Technique for Breast Conserving Surgery: The Rhomboid Rotation Glandular Flap.
    Clin Breast Cancer. 2025;25:667-671.
    PubMed         Abstract available
    
    
25. WEINER N, Niv Y, Sharon E
    Decrease in Calcifications After Neoadjuvant Treatment Predicts Invasive Tumor Response but Not Complete DCIS Eradication: Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025;25:e990-e1000.
    PubMed         Abstract available
    
    
26. WOOLDRIK SM, Wilhelmus S, van Dalen T, Struik GM, et al
    Prognostic Ability of the Indication for Adjuvant Systemic Therapy Based on Preoperative Biopsy and the Surgical Excision Specimen in Cases of Small Breast Tumors (CONSCIENCE): A Retrospective Cohort Study.
    Clin Breast Cancer. 2025;25:e897-e902.
    PubMed         Abstract available
    
    
27. SORAN A, Gultekin MB, Venkatesulu BP, Barry PN, et al
    Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers (Protocol MF22-02): International Multicenter Real-World Data.
    Clin Breast Cancer. 2025;25:e887-e896.
    PubMed         Abstract available
    
    
28. KNOEDLER S, Matar DY, Schaschinger T, Boroumand S, et al
    Single-Pedicled, Supercharged, or Bi-Pedicled? A Multi-Institutional Outcome Comparison of Pedicled TRAM Flap for Autologous Breast Reconstruction.
    Clin Breast Cancer. 2025;25:e857-e867.
    PubMed         Abstract available
    
    
29. LI X, Jiang L, Gao J, Zheng D, et al
    MRI Features and Apparent Diffusion Coefficient Histogram-Based Nomogram for Classifying MRI-Only Suspicious Breast Lesions.
    Clin Breast Cancer. 2025;25:e875-e885.
    PubMed         Abstract available
    
    
30. ABRAHAM AS, Mehta P, Girotra G, Yadav N, et al
    A Randomized Trial Comparing Ultrasound Guided Modified Pectoral Block Versus Erector Spinae Block for Post Mastectomy Pain Management: A Comparative Analysis.
    Clin Breast Cancer. 2025;25:e868-e874.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

31. ZUO H, Vaihenberg E, Singh A, Bal G, et al
    Response to Letter Re: Impact of early discontinuation of adjuvant endocrine therapy on survival in breast cancer: A target trial emulation.
    Eur J Cancer. 2025;229:115781.
    PubMed        
    
    
32. HANVIC B, Joureau-Chabert A, Ouldbey Y, Toussaint P, et al
    Compression therapy with surgical gloves compared to cold therapy with frozen gloves in preventing paclitaxel-induced peripheral neuropathy: Results from the prospective ELEGANT trial in patients with breast cancer.
    Eur J Cancer. 2025;229:115791.
    PubMed         Abstract available
    
    
33. ALPERT A, Shirron N, Shirman Y, Goshen-Lago T, et al
    Deciphering the proteomic landscape of pregnancy-associated colorectal cancer.
    Eur J Cancer. 2025;228:115718.
    PubMed         Abstract available
    
    
34. SALFI G, Olivier T
    When suboptimal post-protocol care in oncology trials is rewarded.
    Eur J Cancer. 2025;228:115702.
    PubMed         Abstract available
    
    

    
    Int J Cancer

35. AZZI E, Bode H, Palviainen T, Hukkanen M, et al
    Long-term impact of stressful life events on breast cancer risk: A 36-year genetically informed prospective study in the Finnish Twin Cohort.
    Int J Cancer. 2025 Sep 13. doi: 10.1002/ijc.70154.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

36. GUNSTER JLB, Groen EJ, Salgado R, Marijnen CAM, et al
    Tumor-infiltrating lymphocytes and preoperative partial breast irradiation in early-stage breast cancer: insights from the prospective PAPBI cohort.
    Int J Radiat Oncol Biol Phys. 2025 Sep 11:S0360-3016(25)06205.
    PubMed         Abstract available
    
    

    
    J Clin Invest

37. SCHOLTEN D, El-Shennawy L, Jia Y, Zhang Y, et al
    Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis.
    J Clin Invest. 2025;135:e193521.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

38. MARTIN M
    Response to Neoadjuvant Chemotherapy and Breast Cancer Subtypes.
    J Clin Oncol. 2025 Sep 15:JCO2501342. doi: 10.1200/JCO-25-01342.
    PubMed        
    
    
39. WINCHESTER DJ
    Reply to: Response to Neoadjuvant Chemotherapy and Breast Cancer Subtypes.
    J Clin Oncol. 2025 Sep 15:JCO2501972. doi: 10.1200/JCO-25-01972.
    PubMed        
    
    
40. CONFORTI F, Merlo F, Pala L, Canzian J, et al
    Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.
    J Clin Oncol. 2025 Sep 17:JCO2501148. doi: 10.1200/JCO-25-01148.
    PubMed        
    
    

    
    J Surg Oncol

41. EPHRAIM R, Kar M, Sultania M, Naik S, et al
    Factors Influencing the Choice of Mastectomy Over Breast Conservation Surgery in Early Breast Cancer: A Prospective Qualitative Exploration of Patient Perspectives From India.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70088.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

42. NGUYEN ST, Nguyen Hoang VA, Nguyen Trieu V, Pham TH, et al
    Author Correction: Personalized mutation tracking in circulating-tumor DNA predicts recurrence in patients with high-risk early breast cancer.
    NPJ Breast Cancer. 2025;11:100.
    PubMed        
    
    
43. BLYTH RRR, Laversin SA, Foxall RB, Savva C, et al
    Author Correction: Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing.
    NPJ Breast Cancer. 2025;11:99.
    PubMed        
    
    

    
    Oncogene

44. CHEN H, Zhou Y, Zhang Y, Fan Y, et al
    TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression.
    Oncogene. 2025 Sep 15. doi: 10.1038/s41388-025-03572.
    PubMed         Abstract available
    
    

    
    Oncol Rep

45. CHEN T, Sun S, Zhou Z, Zhang X, et al
    Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review).
    Oncol Rep. 2025;54:153.
    PubMed         Abstract available
    
    

    
    PLoS One

46. PRADO SOUSA AC, Duran-Prado M, Villar M, Gonzalez-Garcia A, et al
    Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro.
    PLoS One. 2025;20:e0331779.
    PubMed         Abstract available
    
    
47. HUNDLEY WW, O'Connell NS, Kirkman DL, Olson KC, et al
    Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213.
    PLoS One. 2025;20:e0318017.
    PubMed         Abstract available
    
    
48. ABDEL-HAMID L, Yogarajah P, Tealab SHA
    Lightweight deep models based on domain adaptation and network pruning for breast cancer HER2 scoring: IHC vs. H&E histopathological images.
    PLoS One. 2025;20:e0332362.
    PubMed         Abstract available
    
    
49. HERNANDEZ N, Pakarinen T, Salminen A, Castro SL, et al
    A systematic approach to study the effects of acquisition parameters and biological factors on computerized mammography analysis using ex vivo human tissue: A protocol description.
    PLoS One. 2025;20:e0321658.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

50. SAGLIMBENI J, Esteva E, Canales J, Perez OA, et al
    Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2504645122.
    PubMed         Abstract available
    
    

    
    Radiology

51. WEIGEL S, Hense HW, Weyer-Elberich V, Gerss J, et al
    False-Positive Recall and False-Positive Biopsy Rates in Mammography Screening: A TOSYMA Trial Subanalysis.
    Radiology. 2025;316:e251014.
    PubMed         Abstract available
    
    
52. MESUROLLE B, El Khoury M
    False-Positive Recall and Biopsy Rates in Breast Cancer Screening: Insights from TOSYMA.
    Radiology. 2025;316:e252367.
    PubMed        
    
    

    
    Radiother Oncol

53. THOMSEN MS, Lorenzen EL, Alsner J, Krogh SL, et al
    Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1.
    Radiother Oncol. 2025 Sep 15:111142. doi: 10.1016/j.radonc.2025.111142.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.